PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

358.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 425.50
  • 52 Week Low: 237.50
  • Currency: UK Pounds
  • Shares Issued: 286.55m
  • Volume: 98,387
  • Market Cap: £1,025.86m

Puretech Health narrows FY operating losses after cutting expenses

By Iain Gilbert

Date: Thursday 15 Apr 2021

LONDON (ShareCast) - (Sharecast News) - Biotechnology company Puretech Health said on Thursday that it had narrowed operating losses in 2020 on the back of a reduction in general and administrative expenses and a modest increase in full-year revenues.
Puretech stated operating losses were cut from $135.39m in 2019 to $119.53m last year after having cut general and administrative expenses from $59.35m to $49.44m and research and development expenses from $85.84m to $81.85m.

Total revenues grew from $9.80m to $11.76m, with a dip in contract revenues from $8.68m to $8.34m being offset by a surge in grant revenues to $3.42m from $1.11m.

However, the FTSE 250-listed firm also stated income from its "other" segment had tumbled from $672.16m to $178.73m, dragging total full-year pre-tax income to $18.96m - a marked reduction on the prior year's print of $478.47m.

Founder and chief executive Daphne Zohar said: "2020 was a year like no other. For our team at PureTech, it was defined both by transformational progress and tremendous resilience, as we realised significant financial, clinical and regulatory milestones while navigating the challenges of a global pandemic.

"We are well-positioned for an exciting year ahead, which we expect will include multiple value drivers across our wholly-owned programs and our founded entities, including at least ten expected clinical trial initiations and nine expected readouts."

As of 0920 BST, Puretech shares were up 0.29% at 413.18p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 358.00p
Change Today -2.00p
% Change -0.56 %
52 Week High 425.50
52 Week Low 237.50
Volume 98,387
Shares Issued 286.55m
Market Cap £1,025.86m

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.43% below the market average15.43% below the market average15.43% below the market average15.43% below the market average15.43% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Price Trend
6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average
6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average
Income Not Available
Growth
88.57% below the market average88.57% below the market average88.57% below the market average88.57% below the market average88.57% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 24-Sep-2021

Time Volume / Share Price
16:35 23,475 @ 358.00p
16:29 34 @ 359.50p
16:29 312 @ 359.50p
16:29 76 @ 359.50p
16:29 324 @ 359.50p

PRTC Key Personnel

CEO Daphne Zohar
Chair Christopher Viehbacher

Top of Page